Livzon Pharmaceutical Group Inc
SZSE:000513

Watchlist Manager
Livzon Pharmaceutical Group Inc Logo
Livzon Pharmaceutical Group Inc
SZSE:000513
Watchlist
Price: 37.94 CNY 0.77%
Market Cap: 35.1B CNY
Have any thoughts about
Livzon Pharmaceutical Group Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Livzon Pharmaceutical Group Inc

Current Assets 17.5B
Cash & Short-Term Investments 11.6B
Receivables 3.8B
Other Current Assets 2.1B
Non-Current Assets 8.1B
Long-Term Investments 1.7B
PP&E 4.7B
Intangibles 850.8m
Other Non-Current Assets 801.4m
Current Liabilities 9.7B
Accounts Payable 631.2m
Accrued Liabilities 350.6m
Short-Term Debt 3B
Other Current Liabilities 5.8B
Non-Current Liabilities 2B
Long-Term Debt 722.1m
Other Non-Current Liabilities 1.2B

Balance Sheet
Livzon Pharmaceutical Group Inc

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
716
798
2 062
7 401
8 564
8 854
9 952
9 145
10 410
11 321
Cash
0
0
0
0
0
0
0
9 125
10 073
11 321
Cash Equivalents
716
798
2 062
7 401
8 564
8 854
9 952
20
338
0
Short-Term Investments
6
7
6
19
16
17
26
183
108
82
Total Receivables
1 430
1 667
2 066
2 612
2 474
2 532
2 998
3 379
4 110
3 655
Accounts Receivables
1 073
1 256
1 464
1 357
1 382
1 472
1 743
1 952
2 415
2 116
Other Receivables
357
411
602
1 255
1 092
1 060
1 255
1 428
1 695
1 539
Inventory
847
984
1 099
1 103
1 117
1 169
1 488
1 663
2 045
2 061
Other Current Assets
166
122
738
225
301
301
164
302
314
148
Total Current Assets
3 166
3 578
5 971
11 360
12 472
12 873
14 627
14 673
16 987
17 266
PP&E Net
3 505
3 731
3 658
3 579
3 622
3 638
3 948
4 563
4 778
4 734
PP&E Gross
3 505
3 731
3 658
3 579
3 622
3 638
3 948
4 563
4 778
4 734
Accumulated Depreciation
1 638
1 853
2 135
2 107
2 354
2 623
2 949
3 281
3 673
4 115
Intangible Assets
258
273
314
289
325
378
488
835
826
714
Goodwill
103
103
103
103
103
103
103
103
103
125
Note Receivable
0
0
0
47
39
39
34
57
3
3
Long-Term Investments
179
249
238
276
596
651
988
1 695
1 738
1 681
Other Long-Term Assets
91
144
246
244
280
294
402
446
432
521
Other Assets
103
103
103
103
103
103
103
103
103
125
Total Assets
7 303
N/A
8 078
+11%
10 529
+30%
15 898
+51%
17 437
+10%
17 976
+3%
20 591
+15%
22 372
+9%
24 868
+11%
25 045
+1%
Liabilities
Accounts Payable
599
637
588
502
636
547
707
791
854
764
Accrued Liabilities
72
83
235
239
300
361
1 252
1 227
523
388
Short-Term Debt
729
549
674
662
2 219
2 077
2 469
3 080
2 646
2 768
Current Portion of Long-Term Debt
0
400
0
0
0
0
9
9
10
660
Other Current Liabilities
1 269
1 486
1 814
3 008
2 215
2 308
1 646
1 819
3 363
3 508
Total Current Liabilities
2 669
3 155
3 311
4 411
5 370
5 294
6 083
6 925
7 397
8 087
Long-Term Debt
467
1
1
1
1
0
370
642
1 986
1 622
Deferred Income Tax
7
12
17
27
54
91
143
157
192
210
Minority Interest
386
464
600
461
1 098
1 108
1 533
1 307
1 060
724
Other Liabilities
77
100
95
226
263
317
354
337
357
359
Total Liabilities
3 606
N/A
3 731
+3%
4 023
+8%
5 125
+27%
6 785
+32%
6 810
+0%
8 484
+25%
9 368
+10%
10 992
+17%
11 002
+0%
Equity
Common Stock
296
397
426
553
719
935
945
938
936
924
Retained Earnings
3 221
3 814
4 400
8 624
8 600
9 042
9 682
10 461
11 182
11 653
Additional Paid In Capital
213
396
1 820
1 715
1 362
1 163
1 560
1 629
1 627
1 322
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
143
211
155
Treasury Stock
0
247
140
67
0
0
250
71
56
0
Other Equity
33
13
1
53
29
26
170
96
24
12
Total Equity
3 697
N/A
4 346
+18%
6 506
+50%
10 773
+66%
10 652
-1%
11 167
+5%
12 107
+8%
13 004
+7%
13 876
+7%
14 042
+1%
Total Liabilities & Equity
7 303
N/A
8 078
+11%
10 529
+30%
15 898
+51%
17 437
+10%
17 976
+3%
20 591
+15%
22 372
+9%
24 868
+11%
25 045
+1%
Shares Outstanding
Common Shares Outstanding
845
872
935
935
935
935
939
918
927
924

See Also

Discover More